Neogen (NEOG) EBT Margin Growth (3y) (2013 - 2026)
Neogen (NEOG) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -480.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -176.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 1,391.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 2,114.00 |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn | -858.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -858.00 |
| Nov 30, 2025 | 576.00 |
| Aug 31, 2025 | 1,591.00 |
| May 31, 2025 | -29,346.00 |
| Feb 28, 2025 | -957.00 |
| Nov 30, 2024 | -21,598.00 |
| Aug 31, 2024 | -2,413.00 |
| May 31, 2024 | -1,851.00 |
| Feb 29, 2024 | -1,623.00 |
| Nov 30, 2023 | -1,844.00 |
| Aug 31, 2023 | -1,739.00 |
| May 31, 2023 | -1,625.00 |
| Feb 28, 2023 | -1,530.00 |
| Nov 30, 2022 | -3,265.00 |
| Aug 31, 2022 | -1,237.00 |
| May 31, 2022 | -427.00 |
| Feb 28, 2022 | -1,183.00 |
| Nov 30, 2021 | -849.00 |
| Aug 31, 2021 | -27.00 |
| May 31, 2021 | -259.00 |